Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064906 · ClinicalTrials.gov registry record · NA
Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03064906 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 24 participants.
The verdict
NCT03064906, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To assess the safety and performance of the Insulet AP (artificial pancreas) system, using the Omnipod® insulin management system, Dexcom G4 Share® AP System and personalized model predictive control algorithm in adults with type 1 diabetes consuming high fat meals and undertaking moderate intensity exercise.
Interventions
- DEVICE Insulet AP (artificial pancreas) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-03-18 |
| Est. Completion | 2017-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03064906
The ClinicalTrials.gov registry entry for NCT03064906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulet AP (artificial pancreas) System is the first listed.
NCT03064906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03064906 about?
NCT03064906 is a clinical study titled "Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)". To assess the safety and performance of the Insulet AP (artificial pancreas) system, using the Omnipod® insulin management system, Dexcom G4 Share® AP System and personalized model predictive control algorithm in adults with type 1 diabetes consuming high fat meals and undertaking moderate intensity...
What is the current status of trial NCT03064906?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-03-18. Estimated completion is 2017-04-07.
What interventions are being tested in trial NCT03064906?
The interventions under investigation include: Insulet AP (artificial pancreas) System (DEVICE).
Who is sponsoring clinical trial NCT03064906?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.